NUCALA (mepolizumab) is for the add-on treatment of patients 6+ with severe eosinophilic asthma. Not for acute bronchospasm or status asthmaticus.

Please See Important Safety Information Below

Every patient with severe eosinophilic asthma has different kinds of needs, which is why it's important to have a treatment available that has options. With the NUCALA Autoinjector, clinicians have the power to choose at-home or in-office administration for appropriate patients aged 12 years and older. Could NUCALA make a difference for your patients?

MPLWCNT210112 October 2021
Produced in USA.